WallStreetZenWallStreetZen

NASDAQ: NMRA
Neumora Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Neumora Therapeutics revenue was $0.00 for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, NMRA annual revenue was $0.0, with N/A growth year-over-year.

NMRA revenue history

Current Revenue
$0.0
Current Earnings
-$236.9M
Current Profit Margin
0%

Be the first to know when NMRA announces revenue.

NMRA Revenue History By Year

NMRA Yearly RevenueNMRA RevenueNMRA ChangeNMRA Revenue Growth
2025-12-31$0.00N/AN/A
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A

1 of 1

Neumora Therapeutics Revenue FAQ

What was NMRA's revenue last quarter?

On Invalid Date, Neumora Therapeutics (NASDAQ: NMRA) reported Q4 2025 revenue of $0.00 up N/A year over year. In the same quarter last year, Neumora Therapeutics's revenue was $0.00.

What was Neumora Therapeutics's revenue in 2025?

Neumora Therapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $0.00, a N/A decrease year over year.

How much does Neumora Therapeutics make in a day?

Based on Neumora Therapeutics annual revenue for the past four years, NMRA makes an average of $0.00 per day.

What was Neumora Therapeutics's annual revenue growth in the past year?

As of Q2 2026, Neumora Therapeutics's revenue has grown null year over year. Neumora Therapeutics's revenue in the past year totaled $0.00.

How much does Neumora Therapeutics make in a year?

Neumora Therapeutics's revenue by year for the past four years is:
  • Neumora Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $0.00, a N/A decrease year over year.
  • Neumora Therapeutics's annual revenue for Dec 31, 2024 was $0.00, a N/A decrease from 2023.
  • Neumora Therapeutics's annual revenue for 2023 was $0.00, a N/A decrease from 2022.
  • Neumora Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.